Sanofi (SNY) Tops Q4 EPS by 74c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- Wall St set to open higher on strong AI-linked earnings, Mideast deal hopes
- Caterpillar stock jumps on strong earnings and revenue beat
- Optical component stocks rally on proposed U.S. ban on Chinese tech
- BofA says this memory stock could double. Here are 5 reasons why
- Merck shares rise on big Q2 earnings beat, adjusted FY outlook
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
Sanofi (SNY) shares slide following Q4 revenue miss
February 1, 2024 8:42 AM ESTSanofi (NASDAQ: SNY) shares are down premarket following its fourth-quarter earnings release, which saw revenue come in below consensus expectations.
The pharmaceutical and healthcare company reported Q4 EPS of EUR1.66, EUR0.74 better than the analyst estimate of EUR0.92. Revenue for the quarter was EUR10.92 billion versus the consensus estimate of EUR12.65 billion.
Q4 sales rose 9.3% year-on-year, with vaccine sales up... More
